A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring

Recruiting now

Conditions studied: Ulcerative Colitis

In brief

The purpose of this study is to evaluate association between ozanimod exposure during pregnancy and subsequent maternal, fetal, and infant outcomes.

Key facts

Study ID

NCT05953402

Run by

Bristol-Myers Squibb

People needed

1182

Starts

2026-04-21

Expected to finish

2034-06-30

Last updated by the study team

2026-06-15

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Currently or recently pregnant
• Diagnosis of UC
• Resident of country where ozanimod is prescribed for the treatment of UC

You may not qualify if…

• Exposure to other S1P therapies at any time during pregnancy
• Other protocol-defined eligibility criteria apply.

Where it is running

• PPD Virtual - PPD - US — Wilmington, North Carolina, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.